Medicis Pharmaceutical's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Medicis Pharmaceutical Corporation (MRX)

Q2 2012 Earnings Call

August 8, 2012 5:15 pm ET

Executives

Jonah Shacknai – Chairman and Chief Executive Officer

Mark A. Prygocki, Sr. – President

Richard D. Peterson – Executive Vice President, Chief Financial Officer and Treasurer

Analysts

Christopher T. Schott – JP Morgan Securities Inc.

Greg P. Waterman – Goldman Sachs & Co.

Gary Nachman – Susquehanna Financial Group LLP

Rebecca M. Forest – Piper Jaffray, Inc.

Daniel Chang – Stifel Nicolaus & Company, Inc.

Ken Cacciatore – Cowen and Company, LLC

Shibani Malhotra – RBC Capital Markets Equity Research

Ronny Gal – Sanford C. Bernstein & Co.

Catherine Arnold – Credit Suisse

Douglas D. Tsao – Barclays Capital, Inc.

David Risinger – Morgan Stanley

Stephen Barr Willoughby – Cleveland Research Co.

Presentation

Operator

Thank you for joining the Medicis Second Quarter 2012 Financial Results Conference Call. Today's call is being recorded and webcast live on the company's website at www.medicis.com in the Investor Relations section. And will be available for replay for 10 business days following this call.

This is a brief reminder that all discussions today include forward-looking statements. These statements are based on current assumptions made by Medicis based on historical trends, current conditions, expected future developments, and other factors the company believes appropriate today.

Factors may cause actual results to differ materially from those projected in forward-looking statements. You can find a discussion of these factors and more information about Medicis in the company's filings with the Securities and Exchange Commission. The assumptions underlying the forward-looking statements can change and Medicis disclaims any obligation to update those statements. Please note that references to non-GAAP figures in this webcast are reconciled to GAAP figures as noted in today's press release, which also can be found on the company's website at www.medicis.com.

If you liked this article you might like

Apple Turns 40 With Little Fanfare as March to Dow 20K Resumes: ICYMI

Medicis Stock Hits New 52-Week High (MRX)

Medicis Pharmaceuticals Corporation (MRX): Today's Featured Drugs Laggard

Medicis Stock To Go Ex-dividend Tomorrow (MRX)

Cramer's 'Mad Money' Recap: The Worse It Gets, the Better